Fundraising Fox

Clarametyx

Columbus, US · 4 known investors

clarametyx.com ↗

Clarametyx develops novel immune-enabling therapeutics targeting bacterial biofilms to modify disease progression in patients with chronic respiratory diseases.

BiotechHealthtechMedical Devices

Founders & leadership

DR
David RichardsExecutive Officer
PG
Peter G. KleinhenzDirector
ML
Michael LaymanDirector
WB
William BaumelDirector
WE
Wayne EmbreeDirector
CB
Chuck BramlageDirector
LE
Larry EdwardsDirector
MT
Michael Triplett IIDirector

Investors · 4

CincyTechCincinnati · $500K – $750K
JobsOhio VenturesColumbus
Ohio Innovation FundDublin · $500K – $4Mvia Faith Voinovich · led
Rev1 VenturesreportedColumbusvia Wayne Embree · board

Reported raises · per SEC filings

Form D private placements
▶$27.5MraisedJan 2024 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David RichardsExecutive Officer
  • Peter G. KleinhenzDirector
  • Michael LaymanDirector
  • William BaumelDirector
  • Wayne EmbreeDirector
  • Chuck BramlageDirector
  • Larry EdwardsDirector
  • Michael Triplett IIDirector
Offering amount
$33.1M
Amount sold
$27.5M
First sale
Jan 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news